Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS OIG Expects Almost $4 Billion In Recoveries From First Half Of Fiscal 2013

This article was originally published in The Gray Sheet

Executive Summary

Its spring 2013 Semiannual Report to Congress says the Office of Inspector General expects recoveries of about $3.8 billion from audits and investigations undertaken in the first half of fiscal year 2013, among other findings.

You may also be interested in...



Reimbursement In Brief

Labs cite problems with molecular diagnostics payment-setting process. PCORI panels include device, diagnostic appointees. More reimbursement news.

Reimbursement In Brief

CMS will be forced to implement 27% cut in physician payments if Congress does not approve a short-term fix by Jan. 1. OIG suggests ways CMS can lower payment amounts for back orthoses. More reimbursement news.

CMS In Brief

CMS announces 8.5% improper payment rate for FY 2012. HHS Office of Inspector General expects $6.9 billion in recoveries from audits and investigations. More CMS news.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032112

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel